A comparison of the antihypertensive effectiveness of a combination of moexipril or sustained-release verapamil with low-dose hydrochlorothiazide

Journal of Clinical Pharmacology

Volumn 36, Issue 8, 1996, Pages 701-706

  Chrysant, Steven G ^a,c   Stimpel, Michael ^b  

^a UNIVERSITY OF OKLAHOMA   (United States)

^b Schwarz Pharma AG   (Germany)

^c UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROCHLOROTHIAZIDE; MOEXIPRIL; VERAPAMIL;

ADULT; AGED; ANTIHYPERTENSIVE ACTIVITY; ANTIHYPERTENSIVE THERAPY; ARTICLE; BACKACHE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COUGHING; DOUBLE BLIND PROCEDURE; DRUG COMBINATION; DRUG EFFECT; DRUG EFFICACY; DRUG POTENTIATION; DRUG THERAPY; ESSENTIAL HYPERTENSION; FEMALE; GASTROINTESTINAL SYMPTOM; HEADACHE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PHARMACOLOGY; RANDOMIZED CONTROLLED TRIAL; SUSTAINED RELEASE PREPARATION;

EID: 0029816522     PISSN: 00912700     EISSN: None     Source Type: Journal    
DOI: 10.1002/j.1552-4604.1996.tb04238.x     Document Type: Article

References (32)

1. Stimpel M, Bonn R, Koch B, Dickstein K: Pharmacology and clinical use of the new ACE inhibitor moexipril. Cardiovasc Drug Rev 1995;13:211-229.
2. Grass GM, Moorehead WT: Evidence for site-specific absorption of a novel ACE inhibitor. Pharm Res 1989;6:759-765.
3. Rosenkranz RP, Hayashi CM, Lakatos I, McClelland DL: Diuretic effects of an ACE inhibitor, RS-10085, and hydrochlorothiazide in the spontaneously hypertensive rat. Proc West Pharmacol Soc 1989;32:221-225.
4. Chrysant SG: Experience with terazosin administered in combination with other antihypertensive agents. Am J Med 1986; 80(Suppl 5B):55-61.
5. Chrysant SG, Chappel C, Farnham DJ, Levin B, Lueg M, McCluskey D, Steiner C: Antihypertensive and metabolic effects of single and combined atenolol regimens. J Clin Pharmacol 1992;32:61-65.
6. Kochar M, Bolek G, Kalbfleisch J, Olzinski P: A 52-week comparison of lisinopril, hydrochlorothiazide, and their combination in hypertension. J Clin Pharmacol 1987;27:373-377.
7. Weinberger MH: Angiotensin converting enzyme inhibitors enhance the antihypertensive efficiency of diuretics and blunt or prevent adverse metabolic effects. J Cardiovasc Pharmacol 1989:13(Suppl 3):1-4.
8. DeQuattro V: Comparison of benazepril and other antihypertensive agents alone and in combination with the diuretic hydrochlorothiazide. Clin Cardiol 1991;14(Suppl IV):28-32.
9. Holland OB, Kuhnert L, Campbell WB, Anderson BJ: Synergistic effect of captopril with hydrochlorothiazide for the treatment of low-renin hypertensive black patients. Hypertension 1983;5: 235-239.
10. Mehla J, Lopez L, Thorman A: Lisinopril versus lisinopril plus hydrochlorothiazide in essential hypertension. Am J Cardiol 1988;61:803-806.
11. Weinberger MH: The influence of an angiotensin converting enzyme inhibitor, captopril, on diuretic-induced metabolic effects in hypertension. Hypertension 1983;5(Suppl III):132-138.
12. Townsend RR, Holland OB: Combination of converting enzyme inhibitor with diuretic for the treatment of hypertension. Arch Intern Med 1990;150:1175-1183.
13. Chrysant SG: Antihypertensive effectiveness of low dose lisinopril/hydrochlorothiazide combination: a large multicenter study. Arch Intern Med 1994;154:737-743.
14. Chrysant SG, Fagan T, Glazer R, Kriegman A: Effects of benazepril and hydrochlorothiazide, given alone and in low-and high-dose combinations, on blood pressure in patients with hypertension. Arch Fam Med 1996;5:17-24.
15. Lacourciere Y, Gagne C: Influence of combination of captopril and hydrochlorothiazide on plasma lipids, lipoproteins and apolipoproteins in primary hypertension. J Hum Hypertens 1993;7:149-152.
16. Lenz T, Schulte KL, Wagner B, Lilienthal J, Gotzen R: Quinapril, hydrochlorothiazide, and combination in patients with moderate to severe hypertension. Eur Heart J 1994;15:940-946.
17. Genthon R: Study of the efficacy and safety of the combination ramipril 2.5 mg plus hydrochlorothiazide 12.5 mg in patients with mild-to-moderate hypertension. Int J Clin Pharmacol Res 1994;14: 1-9.
18. Middlemost SJ, Tager R, Davis J, Sareli P: Effectiveness of enalapril in combination with low-dose hydrochlorothiazide versus enalapril alone for mild to moderate systemic hypertension in black patients. Am J Cardiol 1994;73:1092-1097.
19. Chrysant SG, Bal IS, Johnson B, McPherson M: A comparative study of captopril and enalapril in patients with severe hypertension. J Clin Pharmacol 1985;25:149-151.
20. Massie B, McCarthy EP, Ramanathan KB, Weis RJ, Anderson M, Eidelson BA, et al: Diltiazem and propranolol in mild to moderate essential hypertension monotherapy or with hydrochlorothiazide. Ann Intern Med 1987;107:150-157.
21. Sever PS, Poulter NR: Calcium antagonists and diuretics as combined therapy. J Hypertens 1986;5(Suppl 5):519-521.
22. Holzgreve H, Distler A, Michaelis J, Philipp T, Wellek S: Verapamil versus hydrochlorothiazide in the treatment of hypertension: results of long term double-blind comparative trial. Br Med J 1989;299:881-886.
23. Chrysant SG, Chrysant C, Trus J, Hitchcock A: Antihypertensive effectiveness of amlodipine in combination with hydrochlorothiazide. Am J Hypertens 1989;2:537-541.
24. Hallin L, Andren L, Hansson L: Controlled trial of nifedipine-bendroflumethiazide in hypertension. J Cardiovasc Pharmacol 1983;5:1083-1085.
25. Cappuccio FP, Markandu ND, Tucker FA, Shore AC, MacGregor GA: A double-blind study of the blood pressure lowering effect of a thiazide diuretic in hypertensive patients already on nifedipine and a beta-blocker. J Hypertens 1987;5:733-738.
26. Weinberger MH: Diuretics and their side effects: dilemma in the treatment of hypertension. Hypertension 1988;II(Suppl II):16-20.
27. Nicholson JP, Resnick LM, Laragh JH: Hydrochlorothiazide is not additive to verapamil in treating essential hypertension. Arch Intern Med 1989;149:125-128.
28. Thanaponavan C, Goulb MS, Eggena P, Barrett JD, Sambhi MP: Renal effects of nitrendipine monotherapy in essential hypertension. J Cardiovasc Pharmacol 1984;6:S1032-S1036.
29. Leonetti G, Cuspidi C, Sampieri L, Terzoli L, Zanchetti A: Cardiovascular, renal and humoral effects of acute administration of two calcium channel blockers in normotensive and hypertensive subjects. J Cardiovasc Pharmacol 1982;4:S319-S324.
30. Ene MD, Williamson PJ, Roberts CJC, Waddell G: Natriuretic effects of nifedipine and nitrendipine (abstract). Br J Clin Pharmacol 1983;17:193P.
31. Chrysant SG, Danisa K, Kem DC, Smith WJ, Dillard BL, Frohlich ED: Racial differences in pressure, volume and renin interrelationships in essential hypertension. Hypertension 1979;1:136-144.
32. Chrysant SG, Neller GK, Dillard BI, Frohlich ED: Effects of diuretics on lipid metabolism in patients with essential hypertension. Angiology 1976;27:707-711.